Intratumoral administration of the Toll‐like receptor 7/8 agonist 3M‐052 enhances interferon‐driven tumor immunogenicity and suppresses metastatic spread in preclinical triple‐negative breast cancer
Damien Zanker(University of Melbourne), Belinda S. Parker(La Trobe University)
Cited by 37
Related Papers
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
|Cancers|2019|728
Neoadjuvant Interferons: Critical for Effective PD-1–Based Immunotherapy in TNBC
|Cancer Immunology Research|2017|80
Myoepithelial cell‐specific expression of stefin A as a suppressor of early breast cancer invasion
|The Journal of Pathology|2017|52